Status:
RECRUITING
Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections
Lead Sponsor:
Boston Children's Hospital
Conditions:
Laboratory-confirmed Bloodstream Infection
Central Line-associated Bloodstream Infections
Eligibility:
All Genders
Brief Summary
Central line-associated bloodstream infections (CLABSIs) are the most common healthcare-associated infection in children and are associated with morbidity and mortality. This study will attempt to ide...
Detailed Description
This is a prospective cohort pilot study at Boston Children's Hospital (BCH) that will explore the source of presumed CLABSI, which we believe may actually have multiple possible sources including MBI...
Eligibility Criteria
Inclusion
- Hospitalized at Boston Children's Hospital
- Central venous catheter of any type including peripherally inserted central catheters (PICC) in any location.
- Laboratory-confirmed bloodstream infection (LCBI) diagnosed by a clinical blood culture growing certain Gram-negative rods
Exclusion
- Patients with CDC-defined secondary bloodstream infections
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02271243
Start Date
November 1 2014
End Date
December 1 2025
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115